Robert W. Baird analyst Jeff Johnson maintained a Buy rating on Envista Holdings (NYSE:NVST) Corp on Monday, setting a price target of $38, which is approximately 2.96% below the present share price of $39.16.
Johnson expects Envista Holdings Corp to post earnings per share (EPS) of $0.68 for the first quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Moderate Buy rating of shares in Envista Holdings, with an average price target of $41.25.
The analysts price targets range from a high of $44 to a low of $38.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $732.3 million and a net profit of $96.8 million. The company's market cap is $6.27 billion.
According to TipRanks.com, Robert W. Baird analyst Jeff Johnson is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 30.5% and a 70.91% success rate.
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments; Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018 and is headquartered in Brea, CA.